Skip to main content

Advertisement

Table 2 Demographic and clinical data of diabetic subjects with and without PAD

From: Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease

  WPAD (n  =  300) PAD (n  =  300) P value
ABI (years  ±  SD) 1.12  ±  0.5 0.67  ±  0.3 0.009
Men/female (n) 199:101 210:90 0.66
Age (years  ±  SD) 73.2  ±  9.1 76.1  ±  5.1 0.19
BMI (kg/m2) 26.2 ± 3.1 25.6 ± 4.2 0.83
Smoking (current) (%) 84 (28.0) 156 (52.0) 0.011
Hypertension (%) 158 (52.6) 201 (67.0) 0.010
CAD (%) 101 (33.6) 186 (62.0) 0.022
Heart failure (%) 33 (11.0) 38 (12.7) 0.82
Diabetes duration (years  ±  SD) 10.1  ±  2.1 11.3  ±  4.1 0.48
Total cholesterol (mmol/l) 5.54 (1.12) 5.98 (1.28) 0.78
HDL-C (mmol/l) 1.41 (1.13) 1.31 (1.14) 0.59
LDL-C (mmol/l) 2.13 (1.22) 2.97 (1.23) 0.02
Triglyceride (mmol/l) 2.12 (1.42) 2.33 (1.47) 0.78
Fasting glucose (mmol/l) 7.22 (1.13) 7.22 (1.43) 0.76
Glycated hemoglobin (%) 7.18 (1.87) 7.94 (1.87) 0.76
eGFR (ml/min per 1.73 m2) 69.23 (11.03) 65.92 (9.12) 0.32
Treatment
  Diet only (%) 44 (14.6) 31 (10.3) 0.36
  Oral agents (%) 164 (54.6) 175 (58.3) 0.87
  Insulin therapy (%) 92 (30.6) 125 (41.6) 0.12
PAD
  1-Fontaine’s II (%)   168 (56.0)  
  2-Fontaine’s III (%)   72 (24.0  
  2-Fontaine’s IV (%)   60 (20.0)